Literature DB >> 33489151

Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19.

Mohamad Y Khatib1, Karimulla S Shaik1, Amna A Ahmed1, Mohammad A Alwraidat1, Ahmed S Mohamed1, Mohamad R Abou Kamar2, Mouhammad Z Sharaf Eldean3, Bashar K Aldaraiseh3, Abdulqadir J Nashwan1.   

Abstract

The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life-threatening bleeding and mortality.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID‐19; cytomegalovirus colitis; double‐barrel colostomy; lower gastrointestinal bleeding; tocilizumab

Year:  2020        PMID: 33489151      PMCID: PMC7813092          DOI: 10.1002/ccr3.3487

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


  13 in total

1.  Cytomegalovirus Reactivation Induced Acute Hepatitis and Gastric Erosions in a Patient with Rheumatoid Arthritis under Treatment with an Anti-IL-6 Receptor Antibody, Tocilizumab.

Authors:  Takuya Komura; Hajime Ohta; Ryotaro Nakai; Jun Seishima; Masatoshi Yamato; Masaki Miyazawa; Kiichiro Kaji; Yohei Marukawa; Takashi Kagaya; Kiyoki Kitagawa; Atsuhiro Kawashima; Shuichi Kaneko; Masashi Unoura
Journal:  Intern Med       Date:  2016-07-15       Impact factor: 1.271

2.  CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.

Authors:  Eva Niv; Baruch Ovadia; Gabriel Groisman; Yael Kopelman
Journal:  Dig Dis Sci       Date:  2020-03-26       Impact factor: 3.199

Review 3.  Intestinal perforation due to cytomegalovirus infection in patients with AIDS.

Authors:  H B Kram; W C Shoemaker
Journal:  Dis Colon Rectum       Date:  1990-12       Impact factor: 4.585

4.  Cytomegalovirus colitis masquerading as rectal malignancy in an immunocompetent patient.

Authors:  Sunitha Jacob; Najah R Zayyani
Journal:  Indian J Pathol Microbiol       Date:  2015 Jan-Mar       Impact factor: 0.740

Review 5.  Cytomegalovirus. A common virus causing serious disease.

Authors:  William Rawlinson; Gillian Scott
Journal:  Aust Fam Physician       Date:  2003-10

Review 6.  Cytomegalovirus infection in immunocompetent critically ill adults: literature review.

Authors:  Awad Al-Omari; Fadi Aljamaan; Waleed Alhazzani; Samer Salih; Yaseen Arabi
Journal:  Ann Intensive Care       Date:  2016-11-03       Impact factor: 6.925

Review 7.  Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review.

Authors:  Chun-Yuan Lee; Yen-Hsu Chen; Po-Liang Lu
Journal:  BMC Infect Dis       Date:  2017-02-01       Impact factor: 3.090

Review 8.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

Review 9.  Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

Authors:  Petros I Rafailidis; Eleni G Mourtzoukou; Ioannis C Varbobitis; Matthew E Falagas
Journal:  Virol J       Date:  2008-03-27       Impact factor: 4.099

10.  Interleukin-6 in Covid-19: A systematic review and meta-analysis.

Authors:  Eric A Coomes; Hourmazd Haghbayan
Journal:  Rev Med Virol       Date:  2020-08-26       Impact factor: 11.043

View more
  6 in total

1.  Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection.

Authors:  Scott Schoninger; Yanina Dubrovskaya; Kassandra Marsh; Diana Altshuler; Prithiv Prasad; Eddie Louie; Scott Weisenberg; Sarah Hochman; David Fridman; Polina Trachuk
Journal:  Open Forum Infect Dis       Date:  2022-06-10       Impact factor: 4.423

2.  Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.

Authors:  Dore C Ananthegowda; Mohamad Y Khatib; Husain S Ali; Mohamed Al Wraidat; Yahia Imam
Journal:  IDCases       Date:  2021-11-23

3.  Characteristics and clinical outcomes of COVID-19 patients with pulmonary disorders: A single-center, retrospective observational study.

Authors:  Wasim Jamal; Mohamad Y Khatib; Mohammad Al Wraidat; Amna Ahmed; Dore C Ananthegowda; Ahmed S Mohamed; Asra Aroos; Prem Chandra; Mansoor Hameed; Muhammad Yousaf; Ahmed Al-Mohammed; Abdulqadir J Nashwan
Journal:  Health Sci Rep       Date:  2022-02-22

4.  Cytomegalovirus gastritis in a patient with severe acute respiratory syndrome coronavirus 2 infection: A case report and literature review.

Authors:  Ehsan Taherifard; Roozbeh Mortazavi; Maral Mokhtari; Ali Taherifard; Sima Kiani Salmi; Erfan Taherifard
Journal:  Respir Med Case Rep       Date:  2022-04-02

5.  First case of concomitant cytomegalovirus (CMV) viremia in non-immunocompromised COVID-19 patient and ICU management strategy in Qatar with literature review.

Authors:  Phool Iqbal; Suresh Menik Arachchige; Yousra Ali; Muhammad Sohaib Qamar; Hani Walid Jaouni; Ahmed Lutfe Mohamad Abdussalam
Journal:  Clin Case Rep       Date:  2022-04-26

6.  Cytomegalovirus pneumonitis amid COVID-19 chaos: the hidden enemy-a case report.

Authors:  Abdulkarim Yousef Aldehaim; Abrar Mohammed Alfaifi; Seham Nehdal Hussain; Abdulaziz Mohammed Alrajhi
Journal:  J Med Case Rep       Date:  2022-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.